The week's pick
Random Articles
Reseach Article
Selective Inhibition of p38 MAPK Isoforms using Bipyrazole Derivatives: An in Silico Approach
| International Journal of Computer Applications |
| Foundation of Computer Science (FCS), NY, USA |
| Volume 130 - Number 2 |
| Year of Publication: 2015 |
| Authors: N. Deepak, Yesu Babu Adimulam, R. Kiran Kumar and |
10.5120/ijca2015906890
|
N. Deepak, Yesu Babu Adimulam, R. Kiran Kumar and . Selective Inhibition of p38 MAPK Isoforms using Bipyrazole Derivatives: An in Silico Approach. International Journal of Computer Applications. 130, 2 ( November 2015), 34-40. DOI=10.5120/ijca2015906890
Abstract
The p38 MAPK family of proteins comprised of four members; p38α, p38β, p38γ, and p38δ. All p38 MAPKs are strongly activated by environmental stresses and inflammatory cytokines. MAPKs have been shown to play a pivotal role in diverse diseases, including cancer. Majority of studies have focussed on targeting p38 MAPK isoform alpha. However, the report computational in silico molecular docking analysis of 34 bipyrazole analogs as possible p38 MAPK inhibitors. Results obtained are compared and it was observed that the top hit in all cases was found to be compound 26 with dock scores more than 200 kcal/mol whereas reported inhibitors in literature SB203580, SB202190, PD169316 resulted in dock scores between 164-189 kcal/mol. Hence, it is worthwhile to study these bipyrazole analogs as a new class of p38 MAPK inhibitors.
References
- W. Xia, M.T. Longaker, G.P. Yang. P38 MAP kinase mediates transforming growth factor-beta2 transcription in human keloid fibroblasts. Am J Physiol Regul Integr Comp Physiol 290 (2006) R501-8.
- M. Schiller, M. Böhm, S. Dennler, J.M. Ehrchen, A. Mauviel. Mitogen- and stress-activated protein kinase 1 is critical for interleukin-1-induced, CREB-mediated, c-fos gene expression in keratinocytes Oncogene 25 (2006) 4449-57.
- A. Cuadrado and A. R. Nebreda. Mechanisms and functions of p38 MAPK signalling, Biochemical Journal 429 (2010) no. 3, 403–417.
- A. Cuenda and S. Rousseau. p38 MAP-kinases pathway regulation, function and role in human diseases, Biochimica et Biophysica Acta 1773 (2007) no. 8, 1358–1375.
- Kumar S, Boehm J, Lee JC. p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases, Nat Rev Drug Discov 2 (2003) 717–726.
- AS Dhillon, S Hagan, O Rath and W Kolch. MAP kinase signalling pathways in cancer. Oncogene 26 (2007) 3279–3290.
- N. Deepak, Dr. A. Yesu babu, Dr. K. Kiran Kumar, In silico pathway analysis of MAPKs and computational investigation of bipyrazole analogs as novel p38-alpha MAPK inhibitors, International Journal of Bioinformatics Research and Applications (Accepted, In Production), 2015.
- F. Bakr Abdel-Wahab and M. Kamal Dawood. Synthesis and applications of bipyrazole systems. ARKIVOC i (2012) 491-545.
- Samir Bondock, Abd El-Gaber Tarhoni and A. Ahmed Fadda. Utility of cyanoacetic acid hydrazide in heterocyclic synthesis. ARKIVOC ix (2006) 113-156.
- C. Dominguez, D.A. Powers, N. Tamayo. P38 MAP kinase inhibitors: many are made, but few are chosen. Curr Opin Drug Discov Devel 8 (2005) 421-30.
Index Terms
Keywords